Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypergammaglobulinemia”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Not applicableEnrolling By InvitationNCT06472830
What this trial is testing

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 1,000
Not applicableStudy completedNCT02033928
What this trial is testing

Comprehensive Frailty Assessment

Who this might be right for
Myeloma, MultipleParaproteinemiasHematologic Neoplasms
Ohio State University Comprehensive Cancer Center 111
Not applicableStudy completedNCT03211689
What this trial is testing

The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease

Who this might be right for
Primary Immune Deficiency DisorderCommon Variable ImmunodeficiencySpecific Antibody Deficiency+1 more
Stockton University 36
Very early researchActive Not RecruitingNCT02603887
What this trial is testing

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 20
Not applicableNot Yet RecruitingNCT06987708
What this trial is testing

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Who this might be right for
Monoclonal Gammopathy of Uncertain SignificanceSmoldering Myeloma
Hackensack Meridian Health 67
Not applicableLooking for participantsNCT05965115
What this trial is testing

The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Shanghai Zhongshan Hospital 10,000
Not applicableWithdrawnNCT01568736
What this trial is testing

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency

Who this might be right for
Hyper IgD SyndromeMevalonate Kinase Deficiency
Michigan Technological University
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Testing effectiveness (Phase 2)Looking for participantsNCT05841550
What this trial is testing

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03679624
What this trial is testing

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; Hypergammaglobulinemia+4 more
Weill Medical College of Cornell University 1
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Not applicableUnknownNCT06497829
What this trial is testing

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency

Who this might be right for
Mevalonate Kinase Deficiency
University Hospital, Motol 6
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT04439006
What this trial is testing

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10
Early research (Phase 1)Active Not RecruitingNCT02886065
What this trial is testing

PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

Who this might be right for
Smoldering Multiple Myeloma
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Looking for participantsNCT03937635
What this trial is testing

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 288
Not applicableEnded earlyNCT00260299
What this trial is testing

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Who this might be right for
Mevalonic AciduriaMevalonate Kinase DeficiencyImmune System Diseases+2 more
Oregon Health and Science University 1
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Large-scale testing (Phase 3)Study completedNCT03301220
What this trial is testing

Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Janssen Research & Development, LLC 390
Next Page